{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:54:42Z","timestamp":1790459682922,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/mt.2016.105","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T20:12:43Z","timestamp":1463861563000},"page":"1570-1580","source":"Crossref","is-referenced-by-count":34,"title":["High Efficiency CRISPR\/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6\/E1b55k \u201cHelper\u201d Proteins"],"prefix":"10.1016","volume":"24","author":[{"given":"Kamila S","family":"Gwiazda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E","family":"Grier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Burleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unja","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia G","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A","family":"Popp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C","family":"Krutein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iram F","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Rawlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M","family":"Scharenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.105_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/hum.2015.074","article-title":"Delivery and specificity of CRISPR-Cas9 genome editing technologies for human gene therapy","volume":"26","author":"Gori","year":"2015","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.105_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev-micro-091014-104441","article-title":"CRISPR-Cas: New tools for genetic manipulations from bacterial immunity systems","volume":"69","author":"Jiang","year":"2015","journal-title":"Annu Rev Microbiol"},{"key":"10.1038\/mt.2016.105_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jgg.2015.02.007","article-title":"A toolkit of CRISPR-based genome editing systems in Drosophila","volume":"42","author":"Xu","year":"2015","journal-title":"J Genet Genomics"},{"key":"10.1038\/mt.2016.105_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc3950","article-title":"Applications of the CRISPR-Cas9 system in cancer biology","volume":"15","author":"S\u00e1nchez-Rivera","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/mt.2016.105_bib5","doi-asserted-by":"crossref","first-page":"e1831","DOI":"10.1038\/cddis.2015.167","article-title":"Genome-editing tools for stem cell biology","volume":"6","author":"Vasileva","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1038\/mt.2016.105_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg3899","article-title":"High-throughput functional genomics using CRISPR-Cas9","volume":"16","author":"Shalem","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mt.2016.105_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.chom.2015.08.012","article-title":"Blowing off steam: Virus inhibition of cGAS DNA sensing","volume":"18","author":"Diner","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1038\/mt.2016.105_bib8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1517\/14728222.2015.1067303","article-title":"Cytosolic sensing of aberrant DNA: arming STING on the endoplasmic reticulum","volume":"19","author":"Wang","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"10.1038\/mt.2016.105_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coviro.2015.08.001","article-title":"Functions of DNA damage machinery in the innate immune response to DNA virus infection","volume":"15","author":"Trigg","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1038\/mt.2016.105_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2015.03.001","article-title":"Intracellular detection of viral nucleic acids","volume":"26","author":"Sparrer","year":"2015","journal-title":"Curr Opin Microbiol"},{"key":"10.1038\/mt.2016.105_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/hum.2012.172","article-title":"Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5","volume":"24","author":"Maier","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.105_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2016.105_bib13","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1093\/nar\/gkv469","article-title":"mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5","volume":"43","author":"Mock","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2016.105_bib14","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1158\/0008-5472.CAN-14-3321","article-title":"Multiplex genome-edited T-cell manufacturing platform for \u201cOff-the-shelf\u201d adoptive T-cell immunotherapies","volume":"75","author":"Poirot","year":"2015","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2016.105_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood-2013-08-521229","article-title":"Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection","volume":"123","author":"Didigu","year":"2014","journal-title":"Blood"},{"key":"10.1038\/mt.2016.105_bib16","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1093\/nar\/gku305","article-title":"TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity","volume":"42","author":"Mussolino","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2016.105_bib17","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/nar\/gkt1224","article-title":"megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering","volume":"42","author":"Boissel","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2016.105_bib18","doi-asserted-by":"crossref","first-page":"307ra156","DOI":"10.1126\/scitranslmed.aac5530","article-title":"Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template","volume":"7","author":"Sather","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2016.105_bib19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2016.105_bib20","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1073\/pnas.1512503112","article-title":"Generation of knock-in primary human T cells using Cas9 ribonucleoproteins","volume":"112","author":"Schumann","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2016.105_bib21","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1128\/JVI.00029-07","article-title":"Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation","volume":"81","author":"Baker","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.105_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/viro.1999.9866","article-title":"Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase","volume":"263","author":"Boyer","year":"1999","journal-title":"Virology"},{"key":"10.1038\/mt.2016.105_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nature00863","article-title":"Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex","volume":"418","author":"Stracker","year":"2002","journal-title":"Nature"},{"key":"10.1038\/mt.2016.105_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/JVI.01990-14","article-title":"Insight into the mechanism of inhibition of adeno-associated virus by the Mre11\/Rad50\/Nbs1 complex","volume":"89","author":"Lentz","year":"2015","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.105_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/10430349950018661","article-title":"Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction","volume":"10","author":"Sanlioglu","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.105_bib26","doi-asserted-by":"crossref","first-page":"12936","DOI":"10.1128\/JVI.01523-07","article-title":"The Mre11\/Rad50\/Nbs1 complex limits adeno-associated virus transduction and replication","volume":"81","author":"Schwartz","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.105_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2015.07.006","article-title":"Adeno-associated virus serotypes for gene therapeutics","volume":"24","author":"Lisowski","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1038\/mt.2016.105_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated viruses for clinical gene therapy","volume":"15","author":"Kotterman","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mt.2016.105_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coviro.2014.07.008","article-title":"Adeno-associated virus: fit to serve","volume":"8","author":"Zinn","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1038\/mt.2016.105_bib30","doi-asserted-by":"crossref","first-page":"9043","DOI":"10.1128\/JVI.00925-08","article-title":"Distinct requirements of adenovirus E1b55K protein for degradation of cellular substrates","volume":"82","author":"Schwartz","year":"2008","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.105_bib31","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1128\/JVI.02134-10","article-title":"The adenovirus E1b55K\/E4orf6 complex induces degradation of the Bloom helicase during infection","volume":"85","author":"Orazio","year":"2011","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.105_bib32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.3198","article-title":"Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells","volume":"33","author":"Chu","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2016.105_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nprot.2011.301","article-title":"AAV-mediated gene targeting methods for human cells","volume":"6","author":"Khan","year":"2011","journal-title":"Nat Protoc"},{"key":"10.1038\/mt.2016.105_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/hgtb.2011.034","article-title":"Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences","volume":"23","author":"Aurnhammer","year":"2012","journal-title":"Hum Gene Ther Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616453335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616453335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T18:53:21Z","timestamp":1536692001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616453335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1525001616453335"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.105","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}